Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's β-amyloid1-42

Journal of Neuroimmunology

Volumn 132, Issue 1-2, 2002, Pages 49-59

  Town, Terrence ^a   Vendrame, Martina ^a   Patel, Anant ^a   Poetter, Daniel ^a   DelleDonne, Anthony ^a   Mori, Takashi ^a   Smeed, Robert ^a   Crawford, Fiona ^a   Klein, Thomas ^a   Tan, Jun ^a   Mullan, Mike ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Alzheimer's disease; Amyloid; Cytokine; T helper cell; Vaccination

Indexed keywords

AMYLOID BETA PROTEIN; CD3 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 4; PHOSPHATE; SODIUM CHLORIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA CHAIN; BRAIN; CELL LEVEL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MARKER; IMMUNIZATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE; SPLEEN; SPLEEN CELL; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; TH1 CELLS; TH2 CELLS;

EID: 0036850612     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00307-7     Document Type: Article

References (20)

1. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch B., Seubert P., Schenk D., Yednock T. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6:2000;916-919.
2. Das P., Murphy M.P., Younkin L.H., Younkin S.G., Golde T.E. Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition. Neurobiol. Aging. 22:2001;721-727.
3. Dickey C.A., Morgan D.G., Kudchodkar S., Weiner D.B., Bai Y., Cao C., Gordon M.N., Ugen K.E. Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1-42 peptide. DNA Cell Biol. 20:2001;723-729.
4. Harris N.L., Ronchese F. The role of B7 costimulation in T-cell immunity. Immunol. Cell Biol. 77:1999;304-311.
5. Himmelrich H., Parra-Lopez C., Tacchini-Cottier F., Louis J.A., Launois P. The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12. J. Immunol. 161:1998;6156-6163.
6. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
7. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., Chishti M.A., Horne P., Heslin D., French J., Mount H.T., Nixon R.A., Mercken M., Bergeron C., Fraser P.E., St George-Hyslop P., Westaway D. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 408:2000;979-982.
8. Lemere C.A., Maron R., Spooner E.T., Grenfell T.J., Mori C., Desai R., Hancock W.W., Weiner H.L., Selkoe D.J. Nasal Abeta treatment induces anti-Abeta antibody production and decreases cerebral amyloid burden in PD-APP mice. Ann. N.Y. Acad. Sci. 920:2000;328-331.
9. Lemere C.A., Maron R., Selkoe D.J., Weiner H.L. Nasal vaccination with beta-amyloid peptide for the treatment of Alzheimer's disease. DNA Cell Biol. 20:2001;705-711.
10. Monsonego A., Maron R., Zota V., Selkoe D.J., Weiner H.L. Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 98:2001;10273-10278.
11. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., Connor K., Hatcher J., Hope C., Gordon M., Arendash G.W. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408:2000;982-985.
12. Nishikomori R., Gurunathan S., Nishikomori K., Strober W. BALB/c mice bearing a transgenic IL-12 receptor beta 2 gene exhibit a nonhealing phenotype to Leishmania major infection despite intact IL-12 signaling. J. Immunol. 166:2001;6776-6783.
13. Romagnani S. T-cell subsets (Th1 versus Th2). Ann. Allergy, Asthma, & Immun. 85:2000;9-18.
14. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
15. Szabo S.J., Dighe A.S., Gubler U., Murphy K.M. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:1997;817-824.
16. Tan J., Newton C.A., Djeu J.Y., Gutsch D.E., Chang A.E., Yang N.S., Klein T.W., Hua Y. Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model. Cancer Res. 56:1996;3399-3403.
17. Tan J., Town T., Paris D., Placzek A., Parker T., Crawford F., Yu H., Humphrey J., Mullan M. Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis. J. Neuroimmunol. 97:1999;77-85.
18. Town T., Tan J., Sansone N., Obregon D., Klein T., Mullan M. Characterization of murine immunoglobulin G antibodies against human amyloid-beta1-42. Neurosci. Lett. 307:2001;101-104.
19. Vehmas A.K., Borchelt D.R., Price D.L., McCarthy D., Wills-Karp M., Peper M.J., Rudow G., Luyinbazi J., Siew L.T., Troncoso J.C. Beta-amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology. DNA Cell Biol. 20:2001;713-721.
20. Wilcock D.M., Gordon M.N., Ugen K.E., Gottschall P.E., DiCarlo G., Dickey C., Boyett K.W., Jantzen P.T., Connor K.E., Melachrino J., Hardy J., Morgan D. Number of Abeta inoculations in APP+PS1 transgenic mice influences antibody titers, microglial activation, and congophilic plaque levels. DNA Cell Biol. 20:2001;731-736.